Electrocorticographic Monitoring of Brain Retraction Injury (EMBRI)
Recruiting now · Not applicable
Conditions studied: Brain Injury, Neurosurgery, Brain Ischemia
In brief
A single centre IDEAL Stage 1 feasibility study using novel electrophysiological recording techniques in adult participants undergoing neurosurgery. This is a first in human study, building upon previous preclinical mice experiments. Participants will undergo their planned neurosurgical procedure as normal. In addition to their standard treatment neurophysiological monitoring including an electrocorticography electrode placed on the brain deep to the retractor will be used to monitor for signs of brain retraction injury.
Key facts
- Study ID
- NCT06409806
- Run by
- University College, London
- People needed
- 6
- Starts
- 2022-08-01
- Expected to finish
- 2026-03-01
- Last updated by the study team
- 2024-09-19
Who can join
Age: 16 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged 16 or older undergoing intracranial surgery where it is anticipated fixed brain retraction will be used.
You may not qualify if…
- Patients without capacity to give consent at time of recruitment
Where it is running
- National Hospital Neurology and Neurosurgery — London, Greater London, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.